Announcements Trials

Browse Landscape

Phase

Status

Unknown 2 Withdrawn 1 Terminated 1 Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 1 Febrile Neutropenia 1

Interventions

Cyclophosphamide 11 fludarabine phosphate 8 fludarabine 8 apixaban 7 Mycophenolic Acid 6 Melphalan 6 Busulfan 6 Whole-Body Irradiation 4 Tacrolimus 4 Rivaroxaban 4 Filgrastim 4 Biopsy 4 thymoglobulin 3 X-Rays 3 Specimen Handling 3 Rituximab 3 Peripheral Blood Stem Cell Transplantation 3 Hematopoietic Stem Cell Transplantation 3 Granulocyte Colony-Stimulating Factor 3 Enoxaparin 3 Bone Marrow Transplantation 3 Azacitidine 3 venetoclax 2 pegylated granulocyte colony-stimulating factor 2 olaparib 2 Tretinoin 2 Stem Cell Transplantation 2 Mesna 2 Injections 2 Heparin, Low-Molecular-Weight 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Meropenem × Classical hematology × Clear all

NCT06293677 2024-07-11

DAR-ARC

Centre Hospitalier Universitaire Vaudois

Phase 4 Recruiting

Classical hematology

Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡